IndraLab

Statements


| 1 1

reach
"In several KRAS mutated cancers, the CD44 molecule associates with ALCAM/CD166 promoting an aggressive phenotype that predicts worse outcome and increased risk of liver and lung metastasis (e.g., colon cancer) (29)."

sparser
"CD44 and ALCAM (CD166) have consistently been associated with tumor growth in xenografts."